Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 1541-1544, 2005; 10.1373/clinchem.2005.050955
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, B.
Right arrow Articles by Yu, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, B.
Right arrow Articles by Yu, R.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2005;51:1541-1544.)
© 2005 American Association for Clinical Chemistry, Inc.


Technical Briefs

Plasma 8-Isoprostane Concentrations in Patients with Age-Related Cataracts

Bin Wang1,a, Huaijun Zhu1, Hong Sun2, Jinshun Pan1, Zhilan Yuan2 and Rongbin Yu3

1 Department of Pharmacology, School of Basic Medical Science, Nanjing Medical University, Nanjing, China;
2 Department of Ophthalmology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China;
3 Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China;

aaddress correspondence to this author at: Department of Pharmacology, School of Basic Medical Science, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China; fax 86-25-86862884, e-mail binwang{at}njmu.edu.cn

Cataracts are the most common cause of blindness and visual dysfunction in the world. Cataractogenesis is a highly complex, multifactorial process. Epidemiologic studies have shown that potential risk factors include age, sex female, exposure to ultraviolet light, smoking, diabetes, and oxidative stress (1)(2)(3)(4). Opacification of the ocular lens may be initiated or promoted by oxidative damage, and data in the literature support an important role of oxidative damage in cataract formation (5)(6). Although animal experiments show evidence for a protective role of antioxidants (7)(8), the association between low concentrations of antioxidants and increased risk of cataracts remains controversial. Whereas some studies have demonstrated such associations, others have not (9)(10).

Isoprostanes are a complex family of compounds produced from arachidonic acid. One of the isoprostanes, 8-isoprostaglandin F2{alpha} (8-iso-PGF2{alpha}), belongs to a family of eicosanoids of nonenzymatic origin (11). 8-Iso-PGF2{alpha} has been widely used as a valid marker of oxidative stress (12)(13). Several methods are currently used to quantify 8-iso-PGF2{alpha}, including gas chromatography–mass spectrometry, gas chromatography–tandem mass spectrometry, and liquid chromatography–tandem mass spectrometry (14)(15), but their cost and technologic requirements limit their routine use. Recently, immunoassays have also been developed to measure 8-iso-PGF2{alpha} (16)(17).

Koliakos et al. (18) found that the mean concentration of 8-iso-PGF2{alpha} in the aqueous humor from cataract patients with exfoliation syndrome was higher than in patients with cataracts only. However, no study has evaluated plasma 8-iso-PGF2{alpha} concentrations in cataract patients.

In this study, we used an enzyme immunoassay to measure the plasma concentrations of 8-iso-PGF2{alpha} in patients with age-related cataracts and in age/sex frequency-matched controls to explore the potential role of systemic oxidative status in the development of cataracts.

Unrelated patients older than 50 years of Chinese nationality with age-related cataracts were recruited at the Nanjing Medical University Affiliated Hospital. Control patients were frequency-matched for age and gender. For each case, a control was matched within the same 5-year age group. All participants had a complete ophthalmologic examination. Cataract status was determined by lens examination with a biomicroscope and ophthalmoscope, and opacities were categorized into nuclear, cortical, posterior capsular, and mixed type (any combination of the above). Controls had no evidence of lens opacity. Patients with other ocular diseases were not included. Individuals with a systemic disease that may cause complicated cataracts were also excluded. Smoking was defined as ≥5 cigarettes/day. The study was approved by the Nanjing Medical University Ethics Committee, and informed consent was obtained from all participants.

Blood samples were obtained in a fasting state between 0800 and 1000 in a quiet, air-conditioned room with the temperature maintained at 22–24 °C and were anticoagulated with EDTA. Plasma samples were separated by centrifugation immediately after blood collection and stored at –80 °C until analysis. 8-Iso-PGF2{alpha} was measure by an enzyme immunoassay (Cayman Chemicals) after purification according to the manufacturer’s specifications. The limit of quantification was 5 ng/L. The intra- and interassay CVs were 7.6% and 8.8%, respectively.

The Kolmogorov–Smirnov test of normality was used to test whether the distribution of variables followed a gaussian pattern. Nonskewed continuous variables are reported as the mean (SD) and compared by means of paired (between cases and controls) or unpaired (between patients with mixed cataracts and patients with pure cataracts) t-tests. Discrete variables are represented as frequencies and were evaluated by the Pearson {chi}2 test. Any differences among 3 or more groups were evaluated by ANOVA with the Scheffé test for continuous variables. The Pearson correlation test was used to assess correlations between the continuous variables. A P value <0.05 was considered to be statistically significant.

A total of 102 cases and 102 controls, frequency-matched on sex and age, were selected. The 2 groups were comparable on the 2 matching variables with similar age distributions and same gender proportions. Males had higher 8-iso-PGF2{alpha} concentrations than females in both the cataract and control groups. We found a significant difference between the 8-iso-PGF2{alpha} concentrations in patients with cataracts and controls [274.3 (90.4) vs 135.5 (24.0) ng/L; P <0.001; Table 1 ]. 8-Iso-PGF2{alpha} was ≤160 ng/L in 10.8% of patients with cataracts, whereas 80.4% of the controls without cataracts had 8-iso-PGF2{alpha} concentrations ≤160 ng/L (P <0.001). Sixty percent of patients received topical ofloxacin, but there was no significant difference in 8-iso-PGF2{alpha} concentrations between patients receiving or not receiving ofloxacin.


View this table:
[in this window]
[in a new window]
 
Table 1. 8-Iso-PGF2{alpha} concentrations in cases and controls and in males vs females.

Analysis of the total population revealed a positive correlation between age and 8-iso-PGF2{alpha} concentration (r = 0.24; P< 0.01). After the exclusion of controls, the 8-iso-PGF2{alpha} concentrations correlated better with age in the case group (r = 0.41; P<0.001; Fig. 1A ).



View larger version (11K):
[in this window]
[in a new window]
 
Figure 1. Age-related plasma concentrations of 8-iso-PGF2{alpha} in the cataract patients.

(A), correlation between age and 8-iso-PGF2{alpha} concentrations in the age-related cataract patients (r = 0.41; P <0.001). (B), box-plot showing stepwise increase of 8-iso-PGF2{alpha} concentrations depending on decade. Median (line inside each box), interquartile range (limits of each box), outliers ({circ}), and extremes (error bars) of 8-iso-PGF2{alpha} concentrations are given (P <0.001 for trend). (C), 8-iso-PGF2{alpha} concentrations in the patients with pure or mixed cataracts. *, P <0.05.

In this age-related cataract group, 8-iso-PGF2{alpha} concentrations increased stepwise, depending on the age decade: 217.0 (83.2) ng/L in patients 51–60 years, 249.7 (78.4) ng/L in patients 61–70 years, 283.6 (75.8) ng/L in patients 71–80 years, and 360.5 (107.9) ng/L in patients older than 80 years (P <0.001). Patients older than 80 years had the significantly highest 8-iso-PGF2{alpha} concentrations (Fig. 1BUp ).

8-Iso-PGF2{alpha} concentrations differed significantly between the different clinical types of opacification. Patients with mixed cataracts, compared with patients with pure (cortical, nuclear, or posterior capsular) cataracts, had higher 8-iso-PGF2{alpha} concentrations [290.9 (97.2) vs 246.3 (70.2) ng/L; P <0.05; Fig. 1CUp ].

Oxidative stress plays a role in the development of many ocular diseases (19)(20). We have already reported that hypoxia-induced retinopathy and production of angiogenic factors in the retina are inhibited by antioxidant (21)(22)(23). Recent data in the literature support an important role of oxidative damage in promoting cataract formation. Kao et al. (24) demonstrated that nitric oxide concentrations in the aqueous humor increased with age in patients with cataracts. Tarwadi et al. (25) reported that plasma thiobarbituric acid–reactive substances were higher in cataract patients than in controls. The activity of erythrocyte catalase was lower and the malondialdehyde concentration in plasma was higher in cataract patients than in controls (26). The association between low antioxidant concentrations and increased risk of cataracts remains controversial. Valero et al. (10) indicated a protective role for vitamin C on the aging lens in a Mediterranean population, and Chasan-Taber et al. (27) reported that dietary carotenoids decrease the risk of cataracts severe enough to require extraction, whereas the Age-Related Eye Disease Study showed no effect of antioxidant formulation on the 7-year risk of development or progression of age-related lens opacities (28). Again, although the Roche European American Cataract Trial demonstrated that daily use of antioxidant micronutrients for 2 years produced a deceleration in progression of age-related cataracts for US patients and for both subgroups (US and UK) after 3 years, there was no significant benefit of treatment in UK patients alone (9).

Isoprostanes are generated by the free radical–mediated peroxidation of arachidonic acid, and 8-isoprostane has been widely used as a valid marker of oxidative stress (11)(12)(13). Koliakos et al. (18) reported that the mean concentration of 8-iso-PGF2{alpha} in aqueous humor from patients with exfoliation syndrome and cataracts was approximately 5 times higher than that measured in the aqueous humor from control cataract patients. However, that study did not evaluate 8-iso-PGF2{alpha} between cataract patients and controls without cataracts. To our knowledge, there are no studies examining the plasma 8-iso-PGF2{alpha} concentration in cataract patients.

Epidemiologic studies have shown that age and female sex are risk factors for cataracts (9)(28). In the present study, cases with cataracts and age/sex frequency-matched controls were selected. The plasma concentrations of 8-iso-PGF2{alpha} were higher in patients with age-related cataracts compared with controls, suggesting that systemic oxidative status may play a role in the development of cataracts. In the age-related cataract group, 8-iso-PGF2{alpha} concentrations were found to correlate well with age. There is a balance between free radical production and antioxidant capacity, but this balance may be destroyed by certain risk factors of cataracts, such as advanced age.

The present study also revealed that 8-iso-PGF2{alpha} concentrations were higher in patients with mixed cataracts than in those with pure cataracts. Different mechanisms may be implicated during development of different types of cataract. Distribution of the glutathione S-transferase genotypes in patients with pure and mixed cataracts are different (29). The nitric oxide concentrations in aqueous humor varied between the clinical types of opacification (24), which can be explained in two ways: (a), in many cases a pure cataract progresses to a mixed cataract involving more than one lens region and becomes more visually disabling, and (b), different processes lead to the formation of pure and mixed opacities.

The vast majority of cataracts are found in developing countries and often result from poverty and poor diet (1)(9)(10). With the population aging, gerontal diseases are becoming a significant social problem in China. Further studies in the Chinese population are needed because of the increasing prevalence of age-related cataracts.

In summary, the present study demonstrates that plasma concentrations of 8-iso-PGF2{alpha} may be a risk factor for cataractogenesis in the Chinese population. These findings may have important implications for understanding the role of systemic oxidative status in the development of cataracts.


Acknowledgments

This project was supported by the National Natural Science Foundation of China (No. 30000207), the Natural Science Foundation of Education Department, Jiangsu Province (No. KJB310001), Commercialization of Science and Technology Foundation of Education Department, Jiangsu Province (JH01-050), and a Nanjing Medical University grant (CX2001003). We are grateful to Dr. Ji-Gao Xiao for expert advice and useful discussions throughout this study.


References

  1. Congdon N, West SK, Buhrmann RR, Kouzis A, Munoz B, Mkocha H. Prevalence of the different types of age-related cataract in an African population. Invest Ophthalmol Vis Sci 2001;42:2478-2482.[Abstract/Free Full Text]
  2. Jacques PF, Moeller SM, Hankinson SE, Chylack LT, Jr, Rogers G, Tung W, et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr 2003;78:400-405.[Abstract/Free Full Text]
  3. Zigler JS, Jr, Qin C, Kamiya T, Krishna MC, Cheng Q, Tumminia S, et al. Tempol-H inhibits opacification of lenses in organ culture. Free Radic Biol Med 2003;35:1194-1202.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  4. Meyer CH, Sekundo W. Nutritional supplementation to prevent cataract formation. Dev Ophthalmol 2005;38:103-119.[CrossRef][Medline] [Order article via Infotrieve]
  5. Garner B, Davies MJ, Truscott RJ. Formation of hydroxyl radicals in the human lens is related to the severity of nuclear cataract. Exp Eye Res 2000;70:81-88.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  6. Marsili S, Salganik RI, Albright CD, Freel CD, Johnsen S, Peiffer RL, et al. Cataract formation in a strain of rats selected for high oxidative stress. Exp Eye Res 2004;79:595-612.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  7. Yoshida M, Kimura H, Kyuki K, Ito M. Combined effect of vitamin E and insulin on cataracts of diabetic rats fed a high cholesterol diet. Biol Pharm Bull 2004;27:338-344.[Medline] [Order article via Infotrieve]
  8. Gupta SK, Trivedi D, Srivastava S, Joshi S, Halder N, Verma SD. Lycopene attenuates oxidative stress induced experimental cataract development: an in vitro and in vivo study. Nutrition 2003;19:794-799.[Medline] [Order article via Infotrieve]
  9. Chylack LT, Jr, Brown NP, Bron A, Hurst M, Kopcke W, Thien U, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002;9:49-80.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  10. Valero MP, Fletcher AE, De Stavola BL, Vioque J, Alepuz VC. Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr 2002;132:1299-1306.[Abstract/Free Full Text]
  11. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 1990;87:9383-9387.[Abstract/Free Full Text]
  12. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  13. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004;18:1791-1800.[Abstract/Free Full Text]
  14. Kim KM, Paeng KJ, Hahm JR, Kim DR, Chung BC. Elevated urinary 8-isoprostaglandin F(2{alpha}) in females with Graves’ hyperthyroidism. Prostaglandins Leukot Essent Fatty Acids 2004;71:143-147.[Medline] [Order article via Infotrieve]
  15. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci 2002;23:360-366.[CrossRef][Medline] [Order article via Infotrieve]
  16. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004;256:308-315.[CrossRef][Medline] [Order article via Infotrieve]
  17. Devaraj S, Hirany SV, Burk RF, Jialal I. Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem 2001;47:1974-1979.[Abstract/Free Full Text]
  18. Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, Hollo G, Katsimbris IE, Georgiadis N, et al. 8-Isoprostaglandin F2{alpha} and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2003;87:353-356.[Abstract/Free Full Text]
  19. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 2003;76:397-403.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  20. Schmidt-Erfurth U. Nutrition and retina. Dev Ophthalmol 2005;38:120-147.[Medline] [Order article via Infotrieve]
  21. Wang B, Zou Y, Li H, Yan H, Pan JS, Yuan ZL. Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1{alpha} in a mouse model of oxygen-induced retinopathy. J Ocul Pharmacol Ther 2005;21:107-113.[Medline] [Order article via Infotrieve]
  22. Wang B, Li H, Yan H, Xiao JG. Genistein inhibited hypoxia inducible factor-1{alpha} expression induced by hypoxia and cobalt chloride in human retinal pigment epithelium cells. Methods Find Exp Clin Pharmacol 2005;27:179-184.[Medline] [Order article via Infotrieve]
  23. Wang B, Zou Y, Yuan ZL, Xiao JG. Genistein suppressed upregulation of vascular endothelial growth factor expression by cobalt chloride and hypoxia in rabbit retinal pigment epithelium cells. J Ocul Pharmacol Ther 2003;19:457-464.[Medline] [Order article via Infotrieve]
  24. Kao CL, Chou CK, Tsai DC, Hsu WM, Liu JH, Wang CS, et al. Nitric oxide levels in the aqueous humor in cataract patients. J Cataract Refract Surg 2002;28:507-512.[Medline] [Order article via Infotrieve]
  25. Tarwadi K, Agte V. Linkages of antioxidant, micronutrient, and socioeconomic status with the degree of oxidative stress and lens opacity in Indian cataract patients. Nutrition 2004;20:261-267.[Medline] [Order article via Infotrieve]
  26. Ates NA, Yildirim O, Tamer L, Unlu A, Ercan B, Muslu N, et al. Plasma catalase activity and malondialdehyde level in patients with cataract. Eye 2004;18:785-788.[CrossRef][Medline] [Order article via Infotrieve]
  27. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, et al. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr 1999;70:509-516.[Abstract/Free Full Text]
  28. . Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and ß carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001;119:1439-1452.[Abstract/Free Full Text]
  29. Juronen E, Tasa G, Veromann S, Parts L, Tiidla A, Pulges R, et al. Polymorphic glutathione S-transferases as genetic risk factors for senile cortical cataract in Estonians. Invest Ophthalmol Vis Sci 2000;41:2262-2267.[Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
CarcinogenesisHome page
H. Zhu, L. Yang, B. Zhou, R. Yu, N. Tang, and B. Wang
Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study
Carcinogenesis, December 1, 2006; 27(12): 2491 - 2496.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, B.
Right arrow Articles by Yu, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, B.
Right arrow Articles by Yu, R.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS